EP0639364A1 - Vessel having a plurality of chambers - Google Patents

Vessel having a plurality of chambers Download PDF

Info

Publication number
EP0639364A1
EP0639364A1 EP93911945A EP93911945A EP0639364A1 EP 0639364 A1 EP0639364 A1 EP 0639364A1 EP 93911945 A EP93911945 A EP 93911945A EP 93911945 A EP93911945 A EP 93911945A EP 0639364 A1 EP0639364 A1 EP 0639364A1
Authority
EP
European Patent Office
Prior art keywords
container
chambers
film
cover
weak seal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP93911945A
Other languages
German (de)
French (fr)
Other versions
EP0639364B1 (en
EP0639364A4 (en
Inventor
Fujio Inoue
Masamitsu Izumi
Shigetoshi Kashiyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26405772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0639364(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of EP0639364A4 publication Critical patent/EP0639364A4/en
Publication of EP0639364A1 publication Critical patent/EP0639364A1/en
Application granted granted Critical
Publication of EP0639364B1 publication Critical patent/EP0639364B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093Containers having several compartments for products to be mixed
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • B65D81/3261Flexible containers having several compartments
    • B65D81/3266Flexible containers having several compartments separated by a common rupturable seal, a clip or other removable fastening device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2024Separating means having peelable seals

Definitions

  • the present invention relates to containers having a plurality of chambers chiefly for use in the field of medicine, and more particularly to flexible containers of plastics having a plurality of chambers for accommodating liquid preparations, powder preparations or solid preparations, and partition means dividing the container into the chambers and permitting communication between the chambers when required.
  • the desiccant which absorbs water from the liquid preparation, fails to fully dry up the hygroscopic medicinal and further causes concentration of the liquid preparation. Because of this drawback, it has not been practice to preserve the hygroscopic and unstable antibiotic or like medicinal and the liquid preparation as separately accommodated in the flexible container of plastics.
  • medicinals such as antibiotics
  • the medicinal is mixed or diluted with, or dissolved in, physiological saline, glucose solution or like dissolving liquid or diluent which is preserved separately.
  • Containers have therefore been developed which comprise a glass vial having enclosed therein an unstable antibiotic and a dissolving liquid-containing flexible container portion of plastics joined to the vial in combination therewith, with a piercing needle provided therebetween (see, for example, Unexamined Japanese Patent Publication HEI 2-1277).
  • These containers have the advantage that the contents can be mixed together with ease aseptically, whereas difficulties are encountered in discarding the container because a very complicated procedure is needed for separating the container into the glass vial, flexible container portion and piercing implement for disposal.
  • the container has a problem as the disposal of medical wastes which has attracted attention presently, i.e., the problem of failing to fulfill the requirement of easy disposal.
  • containers having a plurality of chambers for accommodating other medicinal which is readily oxidizable such as amino acid solution containing tryptophan, and a sugar or electrolytic solution
  • the container of this type must be preserved as placed in an expensive moisture- and gas-barrier outer bag together with an oxygen absorber.
  • the latter preparation sugar or electrolyte solution
  • the outer bag therefore requires a larger capacity, an oxygen absorber having an increased capacity to absorb oxygen or an increased amount of absorber, and a larger amount of moisture- and gas-barrier material, hence the drawback of an increased cost.
  • An object of the present invention is to provide a flexible container of plastics having a plurality of chambers and usable for accommodating and preserving liquid preparations, powder preparations or solid preparations which are hygroscopic or susceptible to oxidation.
  • Another object of the present invention is to provide such a container which can be prepared with use of a reduced amount of expensive moisture- and gas-barrier film and which is therefore inexpensive.
  • Still another object of the present invention is to provide a container of the type mentioned which need not include a glass vial and which is therefore easy to dispose of.
  • Another object of the present invention is to provide such a container wherein at least one of the chambers contains a liquid, powder or solid medicinal preparation which is hygroscopic or susceptible to oxidation, only this chamber being separated from outside moisture and oxygen and adapted to prevent the preparation from oxidation or absorbing moisture without enclosing any oxygen absorber nor desiccant therein.
  • the present invention provides a container having a plurality of chambers for accommodating a liquid, powder or solid and partition means dividing the container into the chambers and permitting communication between the chambers when required, the container being characterized in that the container comprises a flexible plastics container body forming the plurality of chambers, at least one of the chambers being enclosed with a cover having a sealed periphery to form a closed space therein around the chamber, the other chamber or chambers being coverless, the cover being made of a flexible film having moisture- and gas-barrier properties, the partition means being formed by at least one weak seal portion easily openable by pressing the chamber to give an increased internal pressure.
  • a usual substance such as a liquid, powder or solid preparation which is not susceptible to oxidation or hygroscopic
  • This chamber is not enclosed with a moisture- and gas-impermeable cover and is therefore low in moisture- and gas-barrier properties, whereas the substance contained therein can be preserved for a long period of time as in common plastics containers since the substance is a usual one.
  • a special substance such as a liquid, powder or solid preparation which is susceptible to oxidation and/or hygroscopic, is accommodated in the chamber enclosed with the cover.
  • the container body forming the chamber is made of plastics, has moisture- and gas-permeability inherent to plastics although very slight and is low in moisture- and gas-barrier properties.
  • the cover enclosing the chamber is made of a special film which is impermeable to moisture and gas, so that the special substance can be preserved for a long period of time free of degradation despite the low moisture- and gas-barrier properties of the plastics container body.
  • the container of the present invention is usable free of any trouble for accommodating medicinals, such as antibiotics, which are hygroscopic and become unstable with time, and liquid preparations such as dissolving solutions or diluents.
  • the container of the present invention has the gas-impermeable cover of expensive special film, whereas the cover is provided on the container only locally and can therefore be formed with use of a small amount of the expensive special film. This serves to minimize the rise in the cost of packaging. A further cost reduction can be achieved since there is no need to enclose an oxygen absorber or desiccant in the cover around the container body.
  • the plurality of chambers of the container of the invention are separated by at least one weak seal portion, which can be opened by a pressure applied from outside to cause the chambers to communicate with each other.
  • Medicinal components can therefore be mixed together aseptically while being held out of contact with outside air.
  • the plastics container body and the cover constituting the container are both flexible and readily deformable, so that the container can be disposed of without the necessity of separation more easily than containers wherein glass or metal is used.
  • FIGS. 1 and 2 show an embodiment of the invention of the type having two weak seal portions.
  • FIG. 1 showing the embodiment, indicated at 1 is a flexible plastics container body which has a discharge port 2.
  • the plastics container body 1 is prepared from two superposed sheets of flexible plastics film 3 by heat seal the sheets together along the outer peripheral edges thereof.
  • the film 3 is not a special one but is an inexpensive plastics film which is generally used for making flexible plastics containers in the field of medicine.
  • FIG. 3 shows an example of film 3 comprising two layers, i.e., an outer layer 3a of polyethylene (hereinafter referred to simply as "PE”), and an inner layer 3b of a blend of PE and polypropylene (hereinafter referred to simply as "PP").
  • PE polyethylene
  • PP polypropylene
  • the plastics container body 1 has two weak seal portions 8a, 8b extending transversely of the container at an intermediate portion of its height and formed by heat sealing.
  • the weak seal portions 8a, 8b are so adapted that the opposed sheets of film can be separated from each other when required by utilizing the internal pressure of the container which is increased as by pressing the container.
  • the seal strength of the weak seal portions must be smaller than that of the peripheral edge portion of the container body 1.
  • the interior of the plastics container body 1 is divided into upper and lower two chambers 1a, 1b by the weak seal portions 8a, 8b.
  • the upper container portion 1A forming the upper chamber 1a is enclosed with a cover 5, while the lower container portion 1B forming the lower chamber 1b is not provided with such a cover 5.
  • the cover 5 is made of a special film 6 which is impermeable to moisture and gas.
  • FIG. 5 shows an example of special film 6, i.e., a multi-layer film comprising an outer layer 6a and an inner layer 6b of PE.
  • the outer layer 6a is an aluminum-covered film such as aluminum-laminated film, an aluminum-deposited film having high moisture- and gas-impermeability or a two-layer film composed of polyvinylidene chloride and polypropylene (PP).
  • the polyvinylidene chloride forming the outer layer 6a may be replaced by a silica-deposited film of polyvinyl alcohol.
  • the cover 5 comprises two sheets of special film 6 which are so arranged as to surround the upper container portion 1A.
  • the parts which are out of contact with the upper container portion 1A are heat sealed to each other, while the parts in contact with the portion 1A are heat sealed to the outer surface of the portion 1A as indicated at 6c, 6c.
  • the bonded lower edge portions 6c, 6c are positioned between the weak seal portions 8a, 8b.
  • FIG. 4 shows the heat sealed joint on an enlarged scale.
  • the lower edge portion 6c of the cover 5 is heat sealed to the space portion 9 between the seal portions 8a, 8b. This obviates the likelihood that the heat sealing operation will give an increased seal strength to the weak seal portions 8a, 8b.
  • the lower edge portion of the cover 5 is heat sealed to the container body 1 over the weak seal portion. Accordingly, it is desired to seal the edge portion under such a condition that the seal strength of the weak seal portion is prevented from increasing to the greatest possible extent, or the seal portion can be easily separated free of trouble even if the seal strength is increased.
  • Such a condition can be determined by suitably selecting the material for the cover and determining the heat sealing conditions as to temperature, time and pressure, whereas this involves considerable limitations.
  • the lower edge portion 6c of the cover 5 can be sealed to the container body 1 without adversely affecting the seal strength of the weak seal portions 8a, 8b. This leads to the advantage that the material for the cover 5 and the sealing conditions are selectable with greater freedom than in the case of the single seal portion.
  • the sealed joint of the lower edge portion 6c is positioned at a greater distance from the chambers 1a, 1b of the container body as will be apparent from FIG. 4. This eliminates the likelihood that the heat of the sealing operation will thermally degrade the medicinal preparations accommodated in the chambers 1a, 1b.
  • Medicinal preparations which are hygroscopic or susceptible to oxidation include many that are susceptible to thermal degradation, whereas the cover 5 lower edge portion can be heat sealed to the container body without the likelihood of thermally degrading such a preparation. Even if one of the two weak seal portions is opened, the other portion prevents the two chambers from communicating with each other.
  • a powder preparation 10 which is hygroscopic and/or susceptible to oxidation is accommodated within the covered upper container portion 1A, while a usual liquid preparation 11, for example, is accommodated within the coverless lower container portion 1B.
  • the temperature at which the seals are formed is the highest for the entire peripheral portion of the plastics container body 1 and the upper edge portion and side edge portions of the cover 5, less high for the lower edge portions of the cover 5 sealed to the container body 1, and lowest for the weak seal portions 8a, 8b. Consequently, the weak seal portions 8a, 8b are the lowest of all the seals in bond strength.
  • FIG. 6 shows a preferred example of process for producing the present container shown in FIGS. 1 and 2. The process will be described below with reference to FIG. 6, (a) to (e).
  • FIG. 6 First as shown in FIG. 6, (a), two sheets of plastics film shown in FIG. 3 are placed over each other so that the inner layers 3b, 3b are brought into contact with each other, and three sides of the assembly are heat-sealed at a temperature about 170 to about 200°C to make a plastics container body 1.
  • weak seal portions 8a, 8b are formed at an intermediate portion of the container body at a temperature about 110 to about 130°C, and a discharge port 2 is attached to the body. Consequently formed are an upper container portion 1A providing an upper chamber, and a lower container portion 1B separated from the portion 1A and providing a lower chamber.
  • a liquid preparation 11 is filled into the lower container portion 1B through the unsealed part thereof.
  • the unsealed parts of the two container portions 1A, 1B are sealed, followed by heating for sterilization with use of high-pressure steam, hot water or the like.
  • one side of the upper container portion 1A is then cut in an aseptic atmosphere as seen in FIG. 6, (c) to open this portion, which is thereafter dried when so required.
  • a cover 5 is provided over the upper container portion 1A using the special film shown in FIG. 5 and is heat-sealed on its three sides.
  • the lower edge portions 6c extending along the weak seal portions 8a, 8b are heat-sealed at a temperature about 130 to 135°C at an intermediate area between the two portions 8a, 8b to avoid heat-sealing of the lower edge portions as superimposed on the weak seal portions.
  • One side of the cover 5 corresponding to the open side of the upper container portion 1A is similarly left open.
  • FIG. 6 (e) shows the container thus obtained and having the two chambers.
  • the weak seal portions can be formed, for example, by pressing a heated seal forming die against the container body by a cylinder device.
  • the die can be of a structure having two ridges spaced apart by a predetermined distance and heatable to a controlled temperature by an electric heater.
  • a liquid preparation can be placed into the covered container portion 1A and a liquid or powder preparation into the coverless container portion 1B, for example, by a process similar to the foregoing exemplary process.
  • the container accommodating these preparations can be prepared by attaching a discharge port 2 to the container body, then placing the specified preparations into the respective container portions 1A, 1B, closing the filling openings, sterilizing the contents by autoclave, then attaching a cover 5 to the upper container portion 1A, and thereafter sealing the side opening of the cover.
  • the upper container portion 1A is formed by a plastics film comprising an outer layer of PE and an inner layer of blend of PE and PP, so that the container portion 1A permits passage of moisture and gas (e.g. oxygen) although in a very small amount.
  • the upper container portion 1A is provided with the cover 5 of special film having moisture- and gas-barrier properties, with the result that the cover 5 functions to overcome the above disadvantage of the upper container portion 1A. Accordingly, a powder preparation which is hygroscopic and/or susceptible to oxidation can be preserved for a long period of time as accommodated in the upper container portion 1A although this portion is formed by plastics.
  • the weak seal portions 8a, 8b separating the upper and lower container portions 1A, 1B are the lowest in seal strength of all the seals. Therefore, when the container portion is pressed to increase the internal pressure of the container portion, the increased pressure separates the weak seal portions 8a, 8b permitting the two container portions 1A, 1B to communicate with each other, whereby the liquid preparation and the powder preparation within the respective container portions 1A, 1B can be mixed together under an aseptic condition into a solution as contemplated.
  • powder preparations for use in the above embodiment are antibiotic, anti-cancer, steroid, antithrombotic, fibrinolytic, vitamin and like preparations which are hygroscopic and susceptible to oxidation and to thermal degradation.
  • useful liquid preparations are physiological saline, glucose solution and like dissolving solutions or diluents.
  • the usual film for making the plastics container body is a multi-layer film of the construction shown in FIG. 3, also usable is a single-layer or multi-layer film prepared from at least one combination of resins selected from among PE, PP and blends of these resins.
  • FIG. 7 shows as an example a three-layer film 35 which comprises an outer layer 31 of linear low-density polyethylene (hereinafter referred to briefly as "LLDPE"), an intermediate layer 33 of resin mixture of LLDPE and low-crystalline (or amorphous) ethylene/ ⁇ -olefin elastomer, and an inner layer 34 of resin mixture of LLDPE and PP.
  • LLDPE linear low-density polyethylene
  • the LLDPE to be used for the inner layer 34 is pretreated at a high temperature in a vacuum as by the devolatilization and stripping process to thereby reduce the content of low-molecular-weight substances with up to about 30 carbon atoms to not higher than a specified value, whereby the interaction between the medicinal preparation and the inner-layer can be prevented favorably.
  • containers can be formed with high stability to withstand sterilization at a high temperature of at least 121°C, for example, with use of high-pressure steam or hot water.
  • high-density polyethylene HDPE
  • a silica-deposited film is used to form at least a layer of the sheet because of its transparency and high impermeability to moisture and gas.
  • FIG. 8 shows a moisture- and gas-impermeable barrier film as an example of such film, i.e., a three-layer film 46 which comprises an outer layer 43 of biaxially oriented PET film, an intermediate layer 44 of silica-deposited PVA film and an inner layer 45 of low-density polyethylene (LDPE) and in which these layers are bonded to one another with a urethane adhesive resin.
  • a multi-layer film at least for the cover so that the material of the innermost layer of the cover is the same as the material of the outermost layer of the plastics container body, whereby a satisfactory heat seal can be formed.
  • LLDPE low-density polyethylene
  • a powder preparation is enclosed in the chamber of the covered container portion and a liquid in the chamber of the coverless container portion according to the foregoing embodiment, the powder preparation and the liquid preparation can be replaced by each other depending on the contemplated purpose.
  • a liquid preparation is accommodated in the covered container portion with a powder preparation enclosed in the other container portion, for example, in the case where the liquid preparation is an amino acid preparation or the like containing cysteine or tryptophan added thereto and susceptible to oxidation, and the powder preparation is a sugar, an electrolyte or a mixture thereof.
  • a liquid preparation is enclosed in the covered container portion with other liquid preparation in the other container portion, for example, in the case where the former liquid preparation is susceptible to oxidation, such as an amino acid preparation containing cysteine or tryptophan, or a vitamin preparation, and the latter liquid preparation is a sugar or electrolytic preparation.
  • the former liquid preparation is susceptible to oxidation, such as an amino acid preparation containing cysteine or tryptophan, or a vitamin preparation
  • the latter liquid preparation is a sugar or electrolytic preparation.
  • the former liquid preparation is a readily oxidizable fat emulsion or the like, and the latter preparation is a sugar or electrolytic preparation.
  • a solid preparation in one of the container portions and a liquid preparation in the other container portion.
  • Other examples of such powder, liquid and solid preparations are various nutrient preparations and curing agents which are given intravenously or enterally (tube or oral feeding).
  • Further cover may be made locally or entirely of an aluminum-covered film to shield the interior from light.
  • the aluminum-covered film used for the cover may be made peelable locally or entirely when the preparation is to be used, if so desired.
  • While the foregoing embodiment is a container having two chambers for accommodating a liquid preparation and one kind of powder preparation individually, such a container can be provided with more than two chambers, for example, as shown in FIG. 9.
  • Disposed inside the cover 5 is a container portion 1A' having chambers 1a1, 1a2 for accommodating two kinds of powder preparations (or a powder preparation and a solid preparation).
  • a liquid preparation is accommodated in the coverless container portion 1B. It is possible to provide a plurality of chambers for liquid preparations besides powder or solid preparations. Weak seal portions are provided between these chambers.
  • an inert gas such as nitrogen gas, carbon dioxide gas or argon gas
  • an inert gas such as nitrogen gas, carbon dioxide gas or argon gas
  • the inert gas When a liquid, powder or solid preparation which is hygroscopic is enclosed in the chambers la, it is desired to enclose dry air, dry nitrogen gas or like dry gas in the space.
  • the inert gas When the inert gas is enclosed, the air in the space is replaced by the inert gas. This ensures a greater effect to prevent oxidation.
  • the dry gas is enclosed, the air in the space is replaced by the dry gas, which therefore assures an enhanced moistureproof effect.
  • the medicinal preparations contained in the container can be given high stability despite the lapse of time by the moisture- and gas-impermeable film covering the chamber or chambers which must be moisture-proof and free of oxidation, and further by enclosing the inert gas or dry gas in the space inside the cover around the container body, without placing an oxygen absorber and/or desiccant into the space unlike the conventional practice.
  • Two weak seal portions need not always be formed, but more than two seal portions or a single seal portion can be provided. Further the weak seal portion need not always be linear but can be V-shaped so as to project approximately toward the center of the covered chamber. When a pressure is applied to one chamber with hand in this case, the force acting to open the weak seal portion will concentrate on the V-shaped portion, with the result that the medicinal components can be mixed together by opening the weak seal portion with a relatively small pressure. In this case, however, there is a likelihood that separation will inadvertently occur in the seal portion during storage or transport of the container, so that it is desirable to carefully determine the heat-sealing condition.
  • the weak seal portion is formed by directly bonding together the inner layers of two sheets forming the container body.
  • the weak seal portion may be formed by heat seal the two sheets together with a multi-layer insert film held therebetween.
  • FIG. 10 shows a modification wherein two-layer insert film is used.
  • Indicated at 3 is a container forming film which is a single-layer or multi-layer film
  • at 18 is a sheet having a high heat seal strength on the innermost layer of the film 3 at one side
  • at 19 is a sheet having a low heat seal strength on the innermost layer of the film 3 on the other side.
  • the film portion 3 and the sheet 19 form a weak seal portions 21a, 21b.
  • the sheet 18 is made of the same material as the film 3, i.e., PE or PP, and the sheet 19 is made of a blend of PE and PP.
  • Two insert films can be used which are each provided for the two weak seal portions respectively.
  • the cover 5 may be heat-sealed in register with the weak seal portion provided that the weak seal portion is held weak, alternatively, the cover can be attached to the container body using an adhesive or the like.
  • the container of the invention is preferably stored or transported as folded in two at the weak seal portions 8a, 8b and as enclosed with an outer bag 50.
  • the seal portion is prevented from opening due to a pressure under the weight of superimposed containers or due to impact on falling.
  • the discharging port 2' may be formed at one end the chamber 1a' which contains a powder preparation 10 such as antibiotic.
  • the chamber 1b' containing a liquid such as a dissolving solution is closed. If a discharging port is formed at a chamber containing a liquid such as dissolving solution, there is a risk of inadvertently administering only the liquid without mixing with the powder preparation especially in an emergency. Such risk can be eliminated by forming the discharging port at the chamber containing the powder preparation such as antibiotic.
  • a discharge port hole 2a is formed in a two-layer plastics film 3 like the one shown in FIG. 3.
  • a discharge port 2 is attached by heat seal to the outer layer, i.e., the PE layer, of the film 3 in register with the hole 2a.
  • the film 3 is then folded in two along a line through the discharge port 2 as shown in FIG. 13, (c).
  • the two flaps of film 3 are heat sealed together at their peripheral portions at a temperature of about 170 to about 200°C except at filling openings 35, 36 for a medicinal preparation and powder preparation to obtain a plastic container body 1.
  • the filling opening 35 may be sealed and the filling opening 36 only may be left unsealed.
  • two parallel weak seal portions 8a, 8b are formed at an intermediate portion of the container body, with a space portion 9 provided therebetween, at a heat sealing temperature of about 110 to about 130°C.
  • the weak seal portion 8b is 10 mm and the weak seal portion 8a is about 5 mm in width.
  • upper and lower container portions 1A, 1B are formed as partitioned by the weak seal portions 8a, 8b.
  • the medicinal preparation 11 is subsequently filled into the lower container portion 1B through the opening 36, and the two filling openings 35, 36 are thereafter sealed off as seen in FIG. 13, (f), followed by sterilization with autoclave.
  • the sterilized body is externally dried, the portion of the opening 35 is cut in an aseptic atmosphere to open the opening 35 again, and clean air is applied to the interior of the upper container portion 1A through the opening 35 for drying and cleaning.
  • the powder preparation 10 is filled into the upper container portion 1A through the opening 35 under an aseptic condition, and the filling opening 35 is thereafter sealed off.
  • a cover 5 is provided to enclose the upper container portion 1A therewith using two sheets of special film 6 shown in FIG. 5.
  • one of the two film sheets is transparent, and the other sheet is nontransparent.
  • the joint 1A1 (see FIG. 13, (h)) of the periphery of the upper container portion 1A, especially at opposite side portions thereof, needs to have a width greater than 5 mm. Usually this width is about 7 to about 10 mm in view of the sealing width of the film 6.
  • the lower edge portion 6c of the cover 5 is sealed at the position of the space portion 9 between the two weak seal portions 8a, 8b.
  • the sealing temperature is about 150 to about 170°C when the film 6 used is transparent, or 130 to 150°C when the film used is a nontransparent aluminum-covered film.
  • FIG. 13 (i) the cover 5 provided around the upper container portion 1A is initially partly open at one side thereof as indicated at 40.
  • An inert gas or dry gas is injected into the space 7 between the cover 5 and the upper container portion 1A through the opening 40, and the opening 40 is thereafter sealed off.
  • FIG. 13, (j) shows the container of the invention having the two chambers and two weak seal portions thus obtained.

Abstract

A vessel having a plurality of chambers for use mainly in the medical field, wherein the interior of the main body of a flexible plastic vessel is partitioned into a plurality of chambers by use of a partitioning means permitting suitable communication between the chambers, out of respective vessel portions of the main body of the plastic vessel, which constitute the plurality of chambers, at least one vessel portion has no cover and at least another vessel portion has a cover, said cover covering the peripheral surface of said vessel portion through a tightly sealed space portion and being formed of flexible film having moisture-proof and gas barrier properties, so that the easily disposable vessel having the plurality of chambers, which is inexpensive and high in quality and performance can be provided.

Description

    TECHNICAL FIELD
  • The present invention relates to containers having a plurality of chambers chiefly for use in the field of medicine, and more particularly to flexible containers of plastics having a plurality of chambers for accommodating liquid preparations, powder preparations or solid preparations, and partition means dividing the container into the chambers and permitting communication between the chambers when required.
  • BACKGROUND ART
  • Flexible containers of plastics have heretofore been used in the field of medicine which have a plurality of chambers, and partition means dividing the container into the chambers and permitting communication between the chambers. Since such a container is likely to permit penetration of moisture or gas even if in a very small amount, there arises a need to place the container, along with a desiccant, into an expensive outer bag having barrier properties against moisture and gas when the container is used for separately preserving an antibiotic or like medicinal which is hygroscopic and becomes unstable with time, and a liquid preparation such as physiological saline, glucose or like solution or dilution. Nevertheless, the desiccant, which absorbs water from the liquid preparation, fails to fully dry up the hygroscopic medicinal and further causes concentration of the liquid preparation. Because of this drawback, it has not been practice to preserve the hygroscopic and unstable antibiotic or like medicinal and the liquid preparation as separately accommodated in the flexible container of plastics.
  • For this reason, medicinals, such as antibiotics, which become unstable with time are preserved in moisture- and gas-impermeable vials or like containers before use. When to be administered to the patient, the medicinal is mixed or diluted with, or dissolved in, physiological saline, glucose solution or like dissolving liquid or diluent which is preserved separately.
  • However, this method is cumbersome to practice and involves the hazard of contamination with bacteria during the handling procedure. Containers have therefore been developed which comprise a glass vial having enclosed therein an unstable antibiotic and a dissolving liquid-containing flexible container portion of plastics joined to the vial in combination therewith, with a piercing needle provided therebetween (see, for example, Unexamined Japanese Patent Publication HEI 2-1277). These containers have the advantage that the contents can be mixed together with ease aseptically, whereas difficulties are encountered in discarding the container because a very complicated procedure is needed for separating the container into the glass vial, flexible container portion and piercing implement for disposal. Thus, the container has a problem as the disposal of medical wastes which has attracted attention presently, i.e., the problem of failing to fulfill the requirement of easy disposal.
  • Also known are containers having a plurality of chambers for accommodating other medicinal which is readily oxidizable, such as amino acid solution containing tryptophan, and a sugar or electrolytic solution (see, for example, Examined Japanese Patent Publication SHO 63-20550). The container of this type must be preserved as placed in an expensive moisture- and gas-barrier outer bag together with an oxygen absorber. In this case, the latter preparation (sugar or electrolyte solution) on which the absorber need not act is also accommodated in the outer bag along with the medicinal. The outer bag therefore requires a larger capacity, an oxygen absorber having an increased capacity to absorb oxygen or an increased amount of absorber, and a larger amount of moisture- and gas-barrier material, hence the drawback of an increased cost.
  • DISCLOSURE OF THE INVENTION
  • An object of the present invention is to provide a flexible container of plastics having a plurality of chambers and usable for accommodating and preserving liquid preparations, powder preparations or solid preparations which are hygroscopic or susceptible to oxidation.
  • Another object of the present invention is to provide such a container which can be prepared with use of a reduced amount of expensive moisture- and gas-barrier film and which is therefore inexpensive.
  • Still another object of the present invention is to provide a container of the type mentioned which need not include a glass vial and which is therefore easy to dispose of.
  • Another object of the present invention is to provide such a container wherein at least one of the chambers contains a liquid, powder or solid medicinal preparation which is hygroscopic or susceptible to oxidation, only this chamber being separated from outside moisture and oxygen and adapted to prevent the preparation from oxidation or absorbing moisture without enclosing any oxygen absorber nor desiccant therein.
  • Other features of the present invention will become apparent from the following description.
  • The present invention provides a container having a plurality of chambers for accommodating a liquid, powder or solid and partition means dividing the container into the chambers and permitting communication between the chambers when required, the container being characterized in that the container comprises a flexible plastics container body forming the plurality of chambers, at least one of the chambers being enclosed with a cover having a sealed periphery to form a closed space therein around the chamber, the other chamber or chambers being coverless, the cover being made of a flexible film having moisture- and gas-barrier properties, the partition means being formed by at least one weak seal portion easily openable by pressing the chamber to give an increased internal pressure.
  • With the container of the present invention, a usual substance, such as a liquid, powder or solid preparation which is not susceptible to oxidation or hygroscopic, is accommodated in the coverless chamber among the chambers of the container. This chamber is not enclosed with a moisture- and gas-impermeable cover and is therefore low in moisture- and gas-barrier properties, whereas the substance contained therein can be preserved for a long period of time as in common plastics containers since the substance is a usual one.
  • On the other hand, a special substance, such as a liquid, powder or solid preparation which is susceptible to oxidation and/or hygroscopic, is accommodated in the chamber enclosed with the cover. The container body forming the chamber is made of plastics, has moisture- and gas-permeability inherent to plastics although very slight and is low in moisture- and gas-barrier properties. However, the cover enclosing the chamber is made of a special film which is impermeable to moisture and gas, so that the special substance can be preserved for a long period of time free of degradation despite the low moisture- and gas-barrier properties of the plastics container body.
  • Accordingly, although made of flexible plastics, the container of the present invention is usable free of any trouble for accommodating medicinals, such as antibiotics, which are hygroscopic and become unstable with time, and liquid preparations such as dissolving solutions or diluents.
  • The container of the present invention has the gas-impermeable cover of expensive special film, whereas the cover is provided on the container only locally and can therefore be formed with use of a small amount of the expensive special film. This serves to minimize the rise in the cost of packaging. A further cost reduction can be achieved since there is no need to enclose an oxygen absorber or desiccant in the cover around the container body.
  • The plurality of chambers of the container of the invention are separated by at least one weak seal portion, which can be opened by a pressure applied from outside to cause the chambers to communicate with each other. Medicinal components can therefore be mixed together aseptically while being held out of contact with outside air. The plastics container body and the cover constituting the container are both flexible and readily deformable, so that the container can be disposed of without the necessity of separation more easily than containers wherein glass or metal is used.
  • BRIEF DESCRIPTION OF THE DRAWINGS
    • FIG. 1 is an enlarged view in vertical section showing the container according to an embodiment of the invention;
    • FIG. 2 is a front view of the same;
    • FIG. 3 is an enlarged sectional view of the portion A in FIG. 1;
    • FIG. 4 is an enlarged sectional view of the portion B in FIG. 1;
    • FIG. 5 is an enlarged sectional view of the portion C in FIG. 1;
    • FIG. 6 is a diagram illustrating stepwise a preferred example of process for producing the container of the invention shown in FIG. 1;
    • FIG. 7 is a sectional view of a part of the plastics container body of the container according to another embodiment of the invention;
    • FIG. 8 is a sectional view of a part of the cover of the container according to another embodiment of the invention;
    • FIG. 9 shows a vertical section of the container according to a further embodiment of the invention;
    • FIG. 10 is an enlarged sectional view of another example of the weak seal portion;
    • FIG. 11 is a perspective view of the container of the invention as enclosed with an outer bag for storage or transportation;
    • FIG. 12 shows a vertical section of the container according to a further embodiment of the invention;
    • FIG. 13 is a diagram illustrating stepwise another preferred example of process for producing the container of the invention.
    BEST MODE OF CARRYING OUT THE INVENTION
  • Embodiments of the present invention will be described below with reference to the accompanying drawings.
  • FIGS. 1 and 2 show an embodiment of the invention of the type having two weak seal portions.
  • Referring to FIG. 1 showing the embodiment, indicated at 1 is a flexible plastics container body which has a discharge port 2.
  • The plastics container body 1 is prepared from two superposed sheets of flexible plastics film 3 by heat seal the sheets together along the outer peripheral edges thereof.
  • The film 3 is not a special one but is an inexpensive plastics film which is generally used for making flexible plastics containers in the field of medicine.
  • FIG. 3 shows an example of film 3 comprising two layers, i.e., an outer layer 3a of polyethylene (hereinafter referred to simply as "PE"), and an inner layer 3b of a blend of PE and polypropylene (hereinafter referred to simply as "PP").
  • As seen in FIG. 1, the plastics container body 1 has two weak seal portions 8a, 8b extending transversely of the container at an intermediate portion of its height and formed by heat sealing.
  • The weak seal portions 8a, 8b are so adapted that the opposed sheets of film can be separated from each other when required by utilizing the internal pressure of the container which is increased as by pressing the container. The seal strength of the weak seal portions must be smaller than that of the peripheral edge portion of the container body 1.
  • The interior of the plastics container body 1 is divided into upper and lower two chambers 1a, 1b by the weak seal portions 8a, 8b. The upper container portion 1A forming the upper chamber 1a is enclosed with a cover 5, while the lower container portion 1B forming the lower chamber 1b is not provided with such a cover 5.
  • The cover 5 is made of a special film 6 which is impermeable to moisture and gas. FIG. 5 shows an example of special film 6, i.e., a multi-layer film comprising an outer layer 6a and an inner layer 6b of PE. The outer layer 6a is an aluminum-covered film such as aluminum-laminated film, an aluminum-deposited film having high moisture- and gas-impermeability or a two-layer film composed of polyvinylidene chloride and polypropylene (PP). The polyvinylidene chloride forming the outer layer 6a may be replaced by a silica-deposited film of polyvinyl alcohol.
  • With reference to FIG. 1, the cover 5 comprises two sheets of special film 6 which are so arranged as to surround the upper container portion 1A. Of the peripheral portions of the sheets of film 6, the parts which are out of contact with the upper container portion 1A are heat sealed to each other, while the parts in contact with the portion 1A are heat sealed to the outer surface of the portion 1A as indicated at 6c, 6c. As seen in FIG. 1, the bonded lower edge portions 6c, 6c are positioned between the weak seal portions 8a, 8b.
  • A space portion 9 is provided between the seal portions 8a, 8b which is substantially unsealed. FIG. 4 shows the heat sealed joint on an enlarged scale. The lower edge portion 6c of the cover 5 is heat sealed to the space portion 9 between the seal portions 8a, 8b. This obviates the likelihood that the heat sealing operation will give an increased seal strength to the weak seal portions 8a, 8b. In the case of the single seal portion type, the lower edge portion of the cover 5 is heat sealed to the container body 1 over the weak seal portion. Accordingly, it is desired to seal the edge portion under such a condition that the seal strength of the weak seal portion is prevented from increasing to the greatest possible extent, or the seal portion can be easily separated free of trouble even if the seal strength is increased. Such a condition can be determined by suitably selecting the material for the cover and determining the heat sealing conditions as to temperature, time and pressure, whereas this involves considerable limitations. In the case of the present embodiment shown in FIGS. 1 and 4, the lower edge portion 6c of the cover 5 can be sealed to the container body 1 without adversely affecting the seal strength of the weak seal portions 8a, 8b. This leads to the advantage that the material for the cover 5 and the sealing conditions are selectable with greater freedom than in the case of the single seal portion. Further with the present embodiment wherein the lower edge portion 6c of the cover 5 is sealed to the space portion 9 between the two weak seal portions 8a, 8b, the sealed joint of the lower edge portion 6c is positioned at a greater distance from the chambers 1a, 1b of the container body as will be apparent from FIG. 4. This eliminates the likelihood that the heat of the sealing operation will thermally degrade the medicinal preparations accommodated in the chambers 1a, 1b. Medicinal preparations which are hygroscopic or susceptible to oxidation include many that are susceptible to thermal degradation, whereas the cover 5 lower edge portion can be heat sealed to the container body without the likelihood of thermally degrading such a preparation. Even if one of the two weak seal portions is opened, the other portion prevents the two chambers from communicating with each other.
  • For example, a powder preparation 10 which is hygroscopic and/or susceptible to oxidation is accommodated within the covered upper container portion 1A, while a usual liquid preparation 11, for example, is accommodated within the coverless lower container portion 1B.
  • The temperature at which the seals are formed is the highest for the entire peripheral portion of the plastics container body 1 and the upper edge portion and side edge portions of the cover 5, less high for the lower edge portions of the cover 5 sealed to the container body 1, and lowest for the weak seal portions 8a, 8b. Consequently, the weak seal portions 8a, 8b are the lowest of all the seals in bond strength.
  • FIG. 6 shows a preferred example of process for producing the present container shown in FIGS. 1 and 2. The process will be described below with reference to FIG. 6, (a) to (e).
  • First as shown in FIG. 6, (a), two sheets of plastics film shown in FIG. 3 are placed over each other so that the inner layers 3b, 3b are brought into contact with each other, and three sides of the assembly are heat-sealed at a temperature about 170 to about 200°C to make a plastics container body 1. Next, weak seal portions 8a, 8b are formed at an intermediate portion of the container body at a temperature about 110 to about 130°C, and a discharge port 2 is attached to the body. Consequently formed are an upper container portion 1A providing an upper chamber, and a lower container portion 1B separated from the portion 1A and providing a lower chamber.
  • Subsequently, a liquid preparation 11 is filled into the lower container portion 1B through the unsealed part thereof. As seen in FIG. 6, (b), the unsealed parts of the two container portions 1A, 1B are sealed, followed by heating for sterilization with use of high-pressure steam, hot water or the like.
  • Thereafter, one side of the upper container portion 1A is then cut in an aseptic atmosphere as seen in FIG. 6, (c) to open this portion, which is thereafter dried when so required.
  • Next as shown in FIG. 6, (d), a cover 5 is provided over the upper container portion 1A using the special film shown in FIG. 5 and is heat-sealed on its three sides. The lower edge portions 6c extending along the weak seal portions 8a, 8b are heat-sealed at a temperature about 130 to 135°C at an intermediate area between the two portions 8a, 8b to avoid heat-sealing of the lower edge portions as superimposed on the weak seal portions. One side of the cover 5 corresponding to the open side of the upper container portion 1A is similarly left open.
  • Finally, a powder preparation 10, such as antibiotics, is accommodated in the upper container portion 1A in an aseptic atmosphere, and the portion 1A and the cover 5 are thereafter sealed at the open side. FIG. 6 (e) shows the container thus obtained and having the two chambers.
  • It is desired to replace the air in the space by N₂ before the opening is sealed for the removal of oxygen. The weak seal portions can be formed, for example, by pressing a heated seal forming die against the container body by a cylinder device. The die can be of a structure having two ridges spaced apart by a predetermined distance and heatable to a controlled temperature by an electric heater.
  • A liquid preparation can be placed into the covered container portion 1A and a liquid or powder preparation into the coverless container portion 1B, for example, by a process similar to the foregoing exemplary process. The container accommodating these preparations can be prepared by attaching a discharge port 2 to the container body, then placing the specified preparations into the respective container portions 1A, 1B, closing the filling openings, sterilizing the contents by autoclave, then attaching a cover 5 to the upper container portion 1A, and thereafter sealing the side opening of the cover.
  • With the containers of the present invention prepared by the processes shown in FIG. 6, the upper container portion 1A is formed by a plastics film comprising an outer layer of PE and an inner layer of blend of PE and PP, so that the container portion 1A permits passage of moisture and gas (e.g. oxygen) although in a very small amount. However, the upper container portion 1A is provided with the cover 5 of special film having moisture- and gas-barrier properties, with the result that the cover 5 functions to overcome the above disadvantage of the upper container portion 1A. Accordingly, a powder preparation which is hygroscopic and/or susceptible to oxidation can be preserved for a long period of time as accommodated in the upper container portion 1A although this portion is formed by plastics. The weak seal portions 8a, 8b separating the upper and lower container portions 1A, 1B are the lowest in seal strength of all the seals. Therefore, when the container portion is pressed to increase the internal pressure of the container portion, the increased pressure separates the weak seal portions 8a, 8b permitting the two container portions 1A, 1B to communicate with each other, whereby the liquid preparation and the powder preparation within the respective container portions 1A, 1B can be mixed together under an aseptic condition into a solution as contemplated.
  • Examples of powder preparations for use in the above embodiment are antibiotic, anti-cancer, steroid, antithrombotic, fibrinolytic, vitamin and like preparations which are hygroscopic and susceptible to oxidation and to thermal degradation. Examples of useful liquid preparations are physiological saline, glucose solution and like dissolving solutions or diluents.
  • While the usual film for making the plastics container body is a multi-layer film of the construction shown in FIG. 3, also usable is a single-layer or multi-layer film prepared from at least one combination of resins selected from among PE, PP and blends of these resins.
  • FIG. 7 shows as an example a three-layer film 35 which comprises an outer layer 31 of linear low-density polyethylene (hereinafter referred to briefly as "LLDPE"), an intermediate layer 33 of resin mixture of LLDPE and low-crystalline (or amorphous) ethylene/α-olefin elastomer, and an inner layer 34 of resin mixture of LLDPE and PP.
  • Further depending on the type of medicinal preparation to be enclosed, low-molecular weight substances contained in the LLDPE present in the inner layer of the inner wall are likely to undergo an inter-action with the preparation with lapse of time, possibly producing a reaction product which would adversely affect the patient. Accordingly, the LLDPE to be used for the inner layer 34 is pretreated at a high temperature in a vacuum as by the devolatilization and stripping process to thereby reduce the content of low-molecular-weight substances with up to about 30 carbon atoms to not higher than a specified value, whereby the interaction between the medicinal preparation and the inner-layer can be prevented favorably.
  • Further when a suitable amount of high-density polyethylene (HDPE) is incorporated into each layer of the three-layer film 35 as required for giving improved heat resistance to the film, containers can be formed with high stability to withstand sterilization at a high temperature of at least 121°C, for example, with use of high-pressure steam or hot water.
  • As special films for the cover, it is possible to use single-layer or multi-layer sheets of polyvinylidene chloride, polyethylene terephthalate (PET), aluminum-covered film, ethylene-vinyl alcohol copolymer (EVOH) or silica-deposited film. Preferably, a silica-deposited film is used to form at least a layer of the sheet because of its transparency and high impermeability to moisture and gas.
  • FIG. 8 shows a moisture- and gas-impermeable barrier film as an example of such film, i.e., a three-layer film 46 which comprises an outer layer 43 of biaxially oriented PET film, an intermediate layer 44 of silica-deposited PVA film and an inner layer 45 of low-density polyethylene (LDPE) and in which these layers are bonded to one another with a urethane adhesive resin. When the cover is to be heat sealed directly to the plastics container body, it is desirable to use a multi-layer film at least for the cover so that the material of the innermost layer of the cover is the same as the material of the outermost layer of the plastics container body, whereby a satisfactory heat seal can be formed. For example, when the outermost layer of the container body is LLDPE, it is desirable to use LLDPE for the innermost layer of the cover.
  • Although a powder preparation is enclosed in the chamber of the covered container portion and a liquid in the chamber of the coverless container portion according to the foregoing embodiment, the powder preparation and the liquid preparation can be replaced by each other depending on the contemplated purpose.
  • A liquid preparation is accommodated in the covered container portion with a powder preparation enclosed in the other container portion, for example, in the case where the liquid preparation is an amino acid preparation or the like containing cysteine or tryptophan added thereto and susceptible to oxidation, and the powder preparation is a sugar, an electrolyte or a mixture thereof.
  • A liquid preparation is enclosed in the covered container portion with other liquid preparation in the other container portion, for example, in the case where the former liquid preparation is susceptible to oxidation, such as an amino acid preparation containing cysteine or tryptophan, or a vitamin preparation, and the latter liquid preparation is a sugar or electrolytic preparation.
  • Another example is such that the former liquid preparation is a readily oxidizable fat emulsion or the like, and the latter preparation is a sugar or electrolytic preparation.
  • Further it is possible to enclose a solid preparation in one of the container portions and a liquid preparation in the other container portion. Other examples of such powder, liquid and solid preparations are various nutrient preparations and curing agents which are given intravenously or enterally (tube or oral feeding).
  • Further cover may be made locally or entirely of an aluminum-covered film to shield the interior from light. The aluminum-covered film used for the cover may be made peelable locally or entirely when the preparation is to be used, if so desired.
  • While the foregoing embodiment is a container having two chambers for accommodating a liquid preparation and one kind of powder preparation individually, such a container can be provided with more than two chambers, for example, as shown in FIG. 9. Disposed inside the cover 5 is a container portion 1A' having chambers 1a₁, 1a₂ for accommodating two kinds of powder preparations (or a powder preparation and a solid preparation). A liquid preparation is accommodated in the coverless container portion 1B. It is possible to provide a plurality of chambers for liquid preparations besides powder or solid preparations. Weak seal portions are provided between these chambers.
  • In the case where a liquid, powder or solid preparation susceptible to oxidation is enclosed in the covered chambers la, it is desired to enclosed an inert gas, such as nitrogen gas, carbon dioxide gas or argon gas, in the space inside the cover 5 around the container body 1. When a liquid, powder or solid preparation which is hygroscopic is enclosed in the chambers la, it is desired to enclose dry air, dry nitrogen gas or like dry gas in the space. When the inert gas is enclosed, the air in the space is replaced by the inert gas. This ensures a greater effect to prevent oxidation. When the dry gas is enclosed, the air in the space is replaced by the dry gas, which therefore assures an enhanced moistureproof effect.
  • The medicinal preparations contained in the container can be given high stability despite the lapse of time by the moisture- and gas-impermeable film covering the chamber or chambers which must be moisture-proof and free of oxidation, and further by enclosing the inert gas or dry gas in the space inside the cover around the container body, without placing an oxygen absorber and/or desiccant into the space unlike the conventional practice.
  • Two weak seal portions need not always be formed, but more than two seal portions or a single seal portion can be provided. Further the weak seal portion need not always be linear but can be V-shaped so as to project approximately toward the center of the covered chamber. When a pressure is applied to one chamber with hand in this case, the force acting to open the weak seal portion will concentrate on the V-shaped portion, with the result that the medicinal components can be mixed together by opening the weak seal portion with a relatively small pressure. In this case, however, there is a likelihood that separation will inadvertently occur in the seal portion during storage or transport of the container, so that it is desirable to carefully determine the heat-sealing condition.
  • With the foregoing embodiment, the weak seal portion is formed by directly bonding together the inner layers of two sheets forming the container body. Alternatively, the weak seal portion may be formed by heat seal the two sheets together with a multi-layer insert film held therebetween. FIG. 10 shows a modification wherein two-layer insert film is used. Indicated at 3 is a container forming film which is a single-layer or multi-layer film, at 18 is a sheet having a high heat seal strength on the innermost layer of the film 3 at one side, and at 19 is a sheet having a low heat seal strength on the innermost layer of the film 3 on the other side. The film portion 3 and the sheet 19 form a weak seal portions 21a, 21b. For example, when the film 3 is a single-layer film of PE or PP, the sheet 18 is made of the same material as the film 3, i.e., PE or PP, and the sheet 19 is made of a blend of PE and PP. Two insert films can be used which are each provided for the two weak seal portions respectively. The cover 5 may be heat-sealed in register with the weak seal portion provided that the weak seal portion is held weak, alternatively, the cover can be attached to the container body using an adhesive or the like.
  • The container of the invention is preferably stored or transported as folded in two at the weak seal portions 8a, 8b and as enclosed with an outer bag 50. When folded in two in this case, the seal portion is prevented from opening due to a pressure under the weight of superimposed containers or due to impact on falling.
  • As shown in FIG. 12, the discharging port 2' may be formed at one end the chamber 1a' which contains a powder preparation 10 such as antibiotic. In this case, the chamber 1b' containing a liquid such as a dissolving solution is closed. If a discharging port is formed at a chamber containing a liquid such as dissolving solution, there is a risk of inadvertently administering only the liquid without mixing with the powder preparation especially in an emergency. Such risk can be eliminated by forming the discharging port at the chamber containing the powder preparation such as antibiotic.
  • Another preferred process for producing the container of the invention is described below with reference to FIG. 13, (a) to (j).
  • As shown in FIG. 13, (a), a discharge port hole 2a is formed in a two-layer plastics film 3 like the one shown in FIG. 3.
  • Next as seen in FIG. 13, (b), a discharge port 2 is attached by heat seal to the outer layer, i.e., the PE layer, of the film 3 in register with the hole 2a. The film 3 is then folded in two along a line through the discharge port 2 as shown in FIG. 13, (c).
  • Subsequently as seen in FIG. 13, (d), the two flaps of film 3 are heat sealed together at their peripheral portions at a temperature of about 170 to about 200°C except at filling openings 35, 36 for a medicinal preparation and powder preparation to obtain a plastic container body 1. The filling opening 35 may be sealed and the filling opening 36 only may be left unsealed.
  • Next as shown in FIG. 13, (e), two parallel weak seal portions 8a, 8b are formed at an intermediate portion of the container body, with a space portion 9 provided therebetween, at a heat sealing temperature of about 110 to about 130°C. To be suitable, the weak seal portion 8b is 10 mm and the weak seal portion 8a is about 5 mm in width.
  • Consequently, upper and lower container portions 1A, 1B are formed as partitioned by the weak seal portions 8a, 8b. The medicinal preparation 11 is subsequently filled into the lower container portion 1B through the opening 36, and the two filling openings 35, 36 are thereafter sealed off as seen in FIG. 13, (f), followed by sterilization with autoclave.
  • Next as seen in FIG. 13, (g), the sterilized body is externally dried, the portion of the opening 35 is cut in an aseptic atmosphere to open the opening 35 again, and clean air is applied to the interior of the upper container portion 1A through the opening 35 for drying and cleaning.
  • Next as shown in FIG. 13, (h), the powder preparation 10 is filled into the upper container portion 1A through the opening 35 under an aseptic condition, and the filling opening 35 is thereafter sealed off.
  • Next as shown in FIG. 13, (i), a cover 5 is provided to enclose the upper container portion 1A therewith using two sheets of special film 6 shown in FIG. 5. Preferably one of the two film sheets is transparent, and the other sheet is nontransparent.
  • To render the filled preparation 10 substantially free from heat when the film 6 is heat sealed to the edge of the upper container portion 1A, it is preferable to provide a spacing of about 5 mm between the sealed joint 6b of the film 6 and the chamber 1a in the upper container portion 1A. For this purpose, the joint 1A₁ (see FIG. 13, (h)) of the periphery of the upper container portion 1A, especially at opposite side portions thereof, needs to have a width greater than 5 mm. Usually this width is about 7 to about 10 mm in view of the sealing width of the film 6.
  • As shown in FIG. 4, the lower edge portion 6c of the cover 5 is sealed at the position of the space portion 9 between the two weak seal portions 8a, 8b. The sealing temperature is about 150 to about 170°C when the film 6 used is transparent, or 130 to 150°C when the film used is a nontransparent aluminum-covered film.
  • As seen in FIG. 13, (i), the cover 5 provided around the upper container portion 1A is initially partly open at one side thereof as indicated at 40. An inert gas or dry gas is injected into the space 7 between the cover 5 and the upper container portion 1A through the opening 40, and the opening 40 is thereafter sealed off. FIG. 13, (j) shows the container of the invention having the two chambers and two weak seal portions thus obtained. With the foregoing embodiment, the heat sealing temperature for forming each joint is selectively set to an optimum temperature range in accordance with the material of the film concerned and the contemplated seal strength. Accordingly, the sealing temperature ranges given above are in no way limitative.
  • Although the present invention has been described above with reference to several embodiments, the invention is in no way limited to these embodiments but can of course be practiced in various modes within the scope of the invention.

Claims (11)

  1. A container having a plurality of chambers for accommodating a liquid, powder or solid and partition means dividing the container into the chambers and permitting communication between the chambers when required, the container being characterized in that the container comprises a flexible plastics container body forming the plurality of chambers, at least one of the chambers being enclosed with a cover having a sealed periphery to form a closed space therein around the chamber, the other chamber or chambers being coverless, the cover being made of a flexible film having moisture- and gas-barrier properties, the partition means being formed by at least one weak seal portion easily openable by pressing the chamber to give an increased internal pressure.
  2. A container as defined in claim 1 wherein at least two weak seal portions are provided at a spacing, and the cover has a heat-sealed edge between the adjacent weak seal portions.
  3. A container as defined in claim 1 wherein an inert gas or dry gas is enclosed in the closed space within the cover around the container body.
  4. A container as defined in claim 1 wherein the covered chamber has accommodated therein a liquid, powder or solid susceptible to oxidation and/or hydgroscopic.
  5. A container as defined in claim 1 wherein the weak seal portion or portions are formed by directly heat-sealing together opposed inner surfaces of a flexible plastics film forming the container body.
  6. A container as defined in claim 1 wherein the weak seal portion or portions are formed by heat-sealing together opposed inner surfaces of a flexible plastics film forming the container body, with an insert film held between the opposed inner surfaces.
  7. A container as defined in claim 1 wherein the container body is formed of a flexible plastics film comprising an outer layer of linear low-density polyethylene, an intermediate layer of resin mixture of linear low-density polyethylene and ethylene/α-olefin elastomer, and an inner layer of resin mixture of linear low-density polyethylene and polypropylene.
  8. A container as defined in claim 1 wherein the cover comprises a layer of silica-deposited resin film.
  9. A container as defined in claim 1 wherein the cover comprises an outer layer of biaxially oriented polyethylene terephthalate film, an intermediate layer of silica-deposited polyvinyl alcohol film, and an inner layer of low-density polyethylene.
  10. A container as defined in claim 1 wherein the cover has an outer surface provided by an aluminum-laminated film.
  11. A container as defined in claim 4 wherein the substance susceptible to oxidation and/or hygroscopic is an antibiotic.
EP93911945A 1992-05-03 1993-04-28 Container having a plurality of chambers Expired - Lifetime EP0639364B1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP14011392 1992-05-03
JP14011392 1992-05-03
JP140113/92 1992-05-03
JP6466993A JP3079403B2 (en) 1992-05-03 1993-02-28 Double chamber container
JP64669/93 1993-02-28
JP6466993 1993-02-28
PCT/JP1993/000558 WO1993021890A1 (en) 1992-05-03 1993-04-28 Vessel having a plurality of chambers

Publications (3)

Publication Number Publication Date
EP0639364A4 EP0639364A4 (en) 1994-10-24
EP0639364A1 true EP0639364A1 (en) 1995-02-22
EP0639364B1 EP0639364B1 (en) 1999-07-28

Family

ID=26405772

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93911945A Expired - Lifetime EP0639364B1 (en) 1992-05-03 1993-04-28 Container having a plurality of chambers

Country Status (21)

Country Link
EP (1) EP0639364B1 (en)
JP (1) JP3079403B2 (en)
CN (1) CN1065742C (en)
AT (1) ATE182464T1 (en)
AU (1) AU654442B2 (en)
CA (1) CA2112661C (en)
DE (1) DE69325801T2 (en)
DK (1) DK0639364T3 (en)
EG (1) EG20103A (en)
ES (1) ES2133399T3 (en)
FI (1) FI107694B (en)
GR (1) GR3031088T3 (en)
HU (1) HU216406B (en)
NO (1) NO303815B1 (en)
PH (1) PH31343A (en)
PL (1) PL172973B1 (en)
PT (1) PT101262B (en)
RU (1) RU2103987C1 (en)
SG (1) SG44684A1 (en)
TW (1) TW216768B (en)
WO (1) WO1993021890A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0737468A3 (en) * 1995-04-11 1997-03-26 Nissho Kk Flexible dual-chambered container
DE19600530A1 (en) * 1996-01-10 1997-07-17 Nutrichem Diaet & Pharma Gmbh Disposable bag for storing e.g. blood, blood plasma, etc.
WO1997037628A1 (en) * 1996-04-10 1997-10-16 Pharmacia & Upjohn Ab Improved containers for parenteral fluids
WO1998041458A1 (en) * 1997-03-17 1998-09-24 Ucb, S.A. Multi-compartment rehydrating container
EP1033124A1 (en) * 1997-10-27 2000-09-06 Otsuka Pharmaceutical Factory, Inc. Packaged ophthalmic perfusate and cleaning fluid bag
US6399387B1 (en) * 1996-07-19 2002-06-04 Pharmacia Ab Colored composition
EP0919216B1 (en) * 1997-11-20 2003-04-02 Nutrichem Diät + Pharma GmbH Double pouch for delivering a fluid substance
WO2003092574A1 (en) * 2002-04-30 2003-11-13 Otsuka Pharmaceutical Factory, Inc. Multiple-chamber medical container and bag for enclosing same
EP1462078A1 (en) 2003-03-26 2004-09-29 Nipro Corporation A medicine bag
FR2859625A1 (en) * 2003-09-11 2005-03-18 Christiane Cinqualbre Medicine preparing bag, has watertight envelope with internal volume, in which one part of volume includes dosage space with series of additive stocks that are released into solution in another part of volume to prepare medicine
EP1526088A2 (en) 2003-10-22 2005-04-27 KPSS Kao Professional Salon Services GmbH Package and method for producing such package.
EP2022461A1 (en) * 2006-05-23 2009-02-11 Nipro Corporation Container
WO2013042063A1 (en) 2011-09-21 2013-03-28 L'oreal Sachet with at least two compartments
FR2981832A1 (en) * 2011-10-28 2013-05-03 Oreal Sachet for packaging e.g. permanent coloring product that is applied on hair, has compartments delimited by four sheets that are made of two identical materials, where materials exhibit different chemical composition
US10226561B2 (en) 2006-06-15 2019-03-12 Metpro Ab Container, system and method for providing a solution

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462526A (en) * 1993-09-15 1995-10-31 Mcgaw, Inc. Flexible, sterile container and method of making and using same
DE4447626C5 (en) 1994-03-29 2007-01-25 Fresenius Ag Medical multi-chamber bag
JP3455789B2 (en) * 1995-02-28 2003-10-14 株式会社大塚製薬工場 Film for multi-chamber container and multi-chamber container
JP3016348B2 (en) * 1995-03-23 2000-03-06 株式会社ニッショー Double chamber container
JP2734413B2 (en) * 1995-07-04 1998-03-30 株式会社ニッショー Infant beverage container
TR199802314T2 (en) * 1996-05-13 1999-03-22 B. Braun Medical, Inc. Flexible, multi-compartment medicine container and the method of making and using this container.
JPH11128315A (en) 1997-11-04 1999-05-18 Material Eng Tech Lab Inc Medical container
JP4768898B2 (en) * 1998-11-30 2011-09-07 味の素株式会社 Method for producing medical drug enclosure and container therefor
US20050194060A1 (en) 2004-03-03 2005-09-08 Vincent Houwaert Peelable seal closure assembly
US7678097B1 (en) 1999-11-12 2010-03-16 Baxter International Inc. Containers and methods for manufacturing same
JP4093004B2 (en) * 2002-09-27 2008-05-28 株式会社デンソー Connector insertion device and method
WO2004080370A1 (en) * 2003-03-12 2004-09-23 Fujimori Kogyo Co., Ltd. Multiple compartment container
JP4336960B2 (en) * 2003-10-20 2009-09-30 株式会社大塚製薬工場 Multi-chamber container
JP4587096B2 (en) * 2004-03-03 2010-11-24 有限会社ケーアールビジネス Medical multi-chamber container with unmixing prevention mechanism
JP4599918B2 (en) * 2004-07-09 2010-12-15 味の素株式会社 Drug storage sealing body and method for forming drug storage sealing body
KR101211552B1 (en) * 2004-08-16 2012-12-12 니프로 가부시키가이샤 Medical multi-layered container and plural chamber container
AU2006239117A1 (en) * 2005-04-28 2006-11-02 Novo Nordisk Health Care Ag A closed container comprising an activated factor VII polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
DE102005028068B4 (en) * 2005-06-16 2016-07-14 Georg Menshen Gmbh & Co. Kg Method for filling a bag-shaped container
JP5118838B2 (en) * 2006-03-31 2013-01-16 株式会社大塚製薬工場 Multi-chamber container
US9004761B2 (en) 2006-05-01 2015-04-14 Baxter International Inc. Multiple chamber container with mistake proof administration system
PT2266521E (en) 2008-03-14 2013-09-06 Otsuka Pharma Co Ltd Plastic ampule
CN101543461B (en) * 2008-03-28 2013-07-31 丽珠集团利民制药厂 Notoginseng triterpenes medical liquor soft package
JP4944850B2 (en) * 2008-08-08 2012-06-06 味の素株式会社 Drug pre-preparation method
US20120074001A1 (en) * 2009-01-12 2012-03-29 Aktivpak, Inc. Packaged products, inserts and compartments for aseptic mixing of substances, along with methods for use therewith
DK2251453T3 (en) * 2009-05-13 2014-07-07 Sio2 Medical Products Inc container Holder
DE102009058445B4 (en) * 2009-12-16 2016-09-15 Fresenius Medical Care Deutschland Gmbh Multi-chamber bags
JP5104884B2 (en) * 2010-01-27 2012-12-19 味の素株式会社 Method for producing medical drug enclosure and container therefor
MX2013008504A (en) * 2011-01-31 2014-02-17 Ajinomoto Kk Multi-chambered container.
JP5967622B2 (en) * 2011-03-04 2016-08-10 学校法人 久留米大学 Preparation of albumin-containing intravenous injection
CN107592851B (en) * 2015-04-30 2019-06-14 克里奥瓦克公司 Package, packaged product, method of releasing at least one agent into a chamber portion of a package, and method of packaging
FR3058638B1 (en) * 2016-11-16 2022-01-14 Technoflex DOUBLE COMPARTMENT MEDICAL POUCH WITH TAB
CN106924042B (en) * 2017-04-12 2019-08-20 中国人民解放军联勤保障部队第九八三医院 Novel transfusion bag
CN106901984B (en) * 2017-04-28 2019-06-04 济南市儿童医院(山东大学齐鲁儿童医院) Novel transfusion bag
CN107985803A (en) * 2017-12-21 2018-05-04 蓝栋林 A kind of novel wet tissue
EP3824864A1 (en) * 2019-11-19 2021-05-26 Holger Rupprecht Multi-chamber container
CN114194576B (en) * 2021-02-08 2023-08-25 杭州圣石科技股份有限公司 Sealed moistureproof package capable of realizing free exchange of internal gas and process

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1486639A1 (en) * 1963-02-23 1969-11-20 Arthur Corella Packaging divided into closed compartments
US3847279A (en) * 1969-11-20 1974-11-12 American Cyanamid Co Package for plural reactable components with rupturable ultrasonic seal
EP0067420A1 (en) * 1981-06-12 1982-12-22 Terumo Corporation High pressure steam sterilized plastic container holding infusion solution and method for manufacturing the same
EP0109983A1 (en) * 1982-10-30 1984-06-13 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Method for manufacturing plastic container containing infusion solution which does not allow deterioration of infusion solution for long period of time
US4731053A (en) * 1986-12-23 1988-03-15 Merck & Co., Inc. Container device for separately storing and mixing two ingredients
EP0263571A2 (en) * 1983-09-15 1988-04-13 BAXTER INTERNATIONAL INC. (a Delaware corporation) An openable seal line especially for a container
WO1988008694A1 (en) * 1987-05-07 1988-11-17 Terumo Kabushiki Kaisha Packed transfusion
EP0513364A1 (en) * 1990-11-07 1992-11-19 Otsuka Pharmaceutical Factory, Inc. Multi-chamber vessel

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6011160A (en) * 1983-06-30 1985-01-21 Shimadzu Corp Moisture analysis meter
JPH01240468A (en) * 1988-03-11 1989-09-26 Mitsui Toatsu Chem Inc Packaging body of raw pineapple
JP2675049B2 (en) * 1988-03-17 1997-11-12 株式会社新素材総合研究所 Container with contents
JPH0639713Y2 (en) * 1989-12-19 1994-10-19 石塚硝子株式会社 Infusion bag
JPH03236847A (en) * 1990-02-14 1991-10-22 Material Eng Tech Lab Inc Drug-contained receptacle having plural chambers

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1486639A1 (en) * 1963-02-23 1969-11-20 Arthur Corella Packaging divided into closed compartments
US3847279A (en) * 1969-11-20 1974-11-12 American Cyanamid Co Package for plural reactable components with rupturable ultrasonic seal
EP0067420A1 (en) * 1981-06-12 1982-12-22 Terumo Corporation High pressure steam sterilized plastic container holding infusion solution and method for manufacturing the same
EP0109983A1 (en) * 1982-10-30 1984-06-13 TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION Method for manufacturing plastic container containing infusion solution which does not allow deterioration of infusion solution for long period of time
EP0263571A2 (en) * 1983-09-15 1988-04-13 BAXTER INTERNATIONAL INC. (a Delaware corporation) An openable seal line especially for a container
US4731053A (en) * 1986-12-23 1988-03-15 Merck & Co., Inc. Container device for separately storing and mixing two ingredients
WO1988008694A1 (en) * 1987-05-07 1988-11-17 Terumo Kabushiki Kaisha Packed transfusion
EP0513364A1 (en) * 1990-11-07 1992-11-19 Otsuka Pharmaceutical Factory, Inc. Multi-chamber vessel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9321890A1 *

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0737468A3 (en) * 1995-04-11 1997-03-26 Nissho Kk Flexible dual-chambered container
DE19600530A1 (en) * 1996-01-10 1997-07-17 Nutrichem Diaet & Pharma Gmbh Disposable bag for storing e.g. blood, blood plasma, etc.
DE19600530C2 (en) * 1996-01-10 2000-02-17 Nutrichem Diaet & Pharma Gmbh Two-chamber bag and method of making the bag
EP1396249A2 (en) 1996-04-10 2004-03-10 Fresenius Kabi AB Containers for parenteral fluids
WO1997037628A1 (en) * 1996-04-10 1997-10-16 Pharmacia & Upjohn Ab Improved containers for parenteral fluids
US6007529A (en) * 1996-04-10 1999-12-28 Pharmacia & Upjohn Ab Containers for parenteral fluids
AU719057B2 (en) * 1996-04-10 2000-05-04 Fresenius Kabi Ab Improved containers for parenteral fluids
EP1396249A3 (en) * 1996-04-10 2004-04-07 Fresenius Kabi AB Containers for parenteral fluids
US6399387B1 (en) * 1996-07-19 2002-06-04 Pharmacia Ab Colored composition
WO1998041458A1 (en) * 1997-03-17 1998-09-24 Ucb, S.A. Multi-compartment rehydrating container
AU735473B2 (en) * 1997-03-17 2001-07-12 Ucb Multi-compartment rehydrating container
EP1033124A4 (en) * 1997-10-27 2004-04-14 Otsuka Pharma Co Ltd Packaged ophthalmic perfusate and cleaning fluid bag
US7047708B2 (en) 1997-10-27 2006-05-23 Otsuka Pharmaceutical Factory, Inc. Method of packaging ocular irrigating solution
EP1033124A1 (en) * 1997-10-27 2000-09-06 Otsuka Pharmaceutical Factory, Inc. Packaged ophthalmic perfusate and cleaning fluid bag
US6764481B1 (en) 1997-10-27 2004-07-20 Otsuka Pharmaceutical Factory, Inc. Packaged ophthalmic perfusate and cleaning fluid bag
EP0919216B1 (en) * 1997-11-20 2003-04-02 Nutrichem Diät + Pharma GmbH Double pouch for delivering a fluid substance
WO2003092574A1 (en) * 2002-04-30 2003-11-13 Otsuka Pharmaceutical Factory, Inc. Multiple-chamber medical container and bag for enclosing same
US8343128B2 (en) 2002-04-30 2013-01-01 Otsuka Pharmaceutical Factory, Inc. Multiple-chamber medical container and bag for enclosing same
AU2003234087B2 (en) * 2002-04-30 2008-04-17 Otsuka Pharmaceutical Factory, Inc. Multiple-chamber medical container and bag for enclosing same
CN100339065C (en) * 2002-04-30 2007-09-26 株式会社大塚制药工厂 Multiple-chamber medical container and bag for enclosing same
EP1462078A1 (en) 2003-03-26 2004-09-29 Nipro Corporation A medicine bag
WO2005025482A1 (en) * 2003-09-11 2005-03-24 Christiane Cinqualbre Flexible container for the extemporaneous preparation or administration and the administration of a liquid product, such as a solute intended for use as a medicament
FR2859625A1 (en) * 2003-09-11 2005-03-18 Christiane Cinqualbre Medicine preparing bag, has watertight envelope with internal volume, in which one part of volume includes dosage space with series of additive stocks that are released into solution in another part of volume to prepare medicine
EP1526088A3 (en) * 2003-10-22 2006-10-18 KPSS Kao Professional Salon Services GmbH Package and method for producing such package.
EP1526088A2 (en) 2003-10-22 2005-04-27 KPSS Kao Professional Salon Services GmbH Package and method for producing such package.
EP2022461A1 (en) * 2006-05-23 2009-02-11 Nipro Corporation Container
EP2022461A4 (en) * 2006-05-23 2014-02-12 Nipro Corp Container
US10226561B2 (en) 2006-06-15 2019-03-12 Metpro Ab Container, system and method for providing a solution
WO2013042063A1 (en) 2011-09-21 2013-03-28 L'oreal Sachet with at least two compartments
FR2981832A1 (en) * 2011-10-28 2013-05-03 Oreal Sachet for packaging e.g. permanent coloring product that is applied on hair, has compartments delimited by four sheets that are made of two identical materials, where materials exhibit different chemical composition

Also Published As

Publication number Publication date
PT101262B (en) 1999-10-29
CA2112661C (en) 2002-02-26
FI107694B (en) 2001-09-28
ATE182464T1 (en) 1999-08-15
DE69325801T2 (en) 1999-11-18
NO934910D0 (en) 1993-12-30
HU216406B (en) 1999-06-28
RU2103987C1 (en) 1998-02-10
EP0639364B1 (en) 1999-07-28
SG44684A1 (en) 1997-12-19
DK0639364T3 (en) 1999-11-29
CN1082881A (en) 1994-03-02
FI935972A0 (en) 1993-12-31
CA2112661A1 (en) 1993-11-11
DE69325801D1 (en) 1999-09-02
NO303815B1 (en) 1998-09-07
WO1993021890A1 (en) 1993-11-11
PT101262A (en) 1994-06-30
AU654442B2 (en) 1994-11-03
TW216768B (en) 1993-12-01
ES2133399T3 (en) 1999-09-16
EP0639364A4 (en) 1994-10-24
FI935972A (en) 1994-02-24
AU4270993A (en) 1993-11-29
NO934910L (en) 1994-01-26
HUT68420A (en) 1995-06-28
PH31343A (en) 1998-07-17
JPH0614975A (en) 1994-01-25
CN1065742C (en) 2001-05-16
PL298768A1 (en) 1994-03-21
JP3079403B2 (en) 2000-08-21
EG20103A (en) 1997-07-31
PL172973B1 (en) 1997-12-31
GR3031088T3 (en) 1999-12-31
HU9400012D0 (en) 1994-05-30

Similar Documents

Publication Publication Date Title
US5423421A (en) Containers having plurality of chambers
EP0639364B1 (en) Container having a plurality of chambers
AU639379B2 (en) Multi-chamber vessel
US5364384A (en) Flexible container with intergral protective cover
US6162205A (en) Container for therapeutic use
JP3060132B2 (en) Double chamber container
JP3060133B2 (en) Double chamber container
JP3707899B2 (en) Multi-chamber container
JP3679219B2 (en) Multi-chamber container
JP3707898B2 (en) Multi-chamber container
JPH1156968A (en) Packaging body for medical container
JP2000334042A (en) Medical syringe
JPH10218252A (en) Container for storing multi-constituent
JPH08215285A (en) Production of double-chamber container
JPH10167341A (en) Packaging structure for medical container
JP2001252333A (en) Double chamber container for medical treatment
KR0169083B1 (en) Container with a plurality of chambers
JPH11169434A (en) Medical container
JPH10338275A (en) Packaging member for medical container
JPH11276549A (en) Container for medical treatment
HU215536B (en) Vessel used mainly in the medical field
JPH10297679A (en) Packaging body
JPH1156969A (en) Packaging body for medical container

Legal Events

Date Code Title Description
A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI NL SE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19931229

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI NL SE

17Q First examination report despatched

Effective date: 19960313

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI NL SE

REF Corresponds to:

Ref document number: 182464

Country of ref document: AT

Date of ref document: 19990815

Kind code of ref document: T

RIN1 Information on inventor provided before grant (corrected)

Inventor name: KASHIYAMA, SHIGETOSHI

Inventor name: IZUMI, MASAMITSU

Inventor name: INOUE, FUJIO

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: RITSCHER & SEIFERT

ITF It: translation for a ep patent filed

Owner name: MANZONI & MANZONI S.R.L.

REF Corresponds to:

Ref document number: 69325801

Country of ref document: DE

Date of ref document: 19990902

ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2133399

Country of ref document: ES

Kind code of ref document: T3

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: SERVOPATENT GMBH

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20070404

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20070412

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20070415

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20070416

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20070423

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20070426

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20070427

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20070615

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20070425

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20070622

Year of fee payment: 15

REG Reference to a national code

Ref country code: CH

Ref legal event code: PFA

Owner name: OTSUKA PHARMACEUTICAL FACTORY, INC.

Free format text: OTSUKA PHARMACEUTICAL FACTORY, INC.#115, AZA KUGUHARA TATEIWA, MUYA-CHO#NARUTO-SHI, TOKUSHIMA 772-8601 (JP) -TRANSFER TO- OTSUKA PHARMACEUTICAL FACTORY, INC.#115, AZA KUGUHARA TATEIWA, MUYA-CHO#NARUTO-SHI, TOKUSHIMA 772-8601 (JP)

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GR

Payment date: 20070321

Year of fee payment: 15

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20070411

Year of fee payment: 15

BERE Be: lapsed

Owner name: *OTSUKA PHARMACEUTICAL FACTORY INC.

Effective date: 20080430

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DK

Ref legal event code: EBP

EUG Se: european patent has lapsed
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20080428

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20081101

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081101

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081101

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20081231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080428

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080430

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20080429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20081104

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080428

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080429

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080428

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20080429